Skip to main content
رجوع
IRTC logo

iRhythm Technologies, Inc.

جودة البيانات: 67%
IRTC
NASDAQ Healthcare Medical - Devices
KWD 118.14
▲ KWD 1.86 (1.60%)
القيمة السوقية: 3.82B
نطاق اليوم
KWD 117.64 KWD 121.24
نطاق 52 أسبوعًا
KWD 92.52 KWD 212.00
حجم التداول
499,976
متوسط 50 يوم / 200 يوم
KWD 144.78 / KWD 160.76
الإغلاق السابق
KWD 116.28

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -85.7 0.4
P/B 2.9
ROE % 3.7
Net Margin % -6.0 3.9
Rev Growth 5Y % 23.3 10.0
D/E 0.2

السعر المستهدف للمحللين

Hold
KWD 210.910 +78.5%
Low: KWD 184.000 High: KWD 244.000
ربحية السهم المستقبلية
-KWD 0.316
الإيرادات المقدّرة
880 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 2.400
KWD 2.368 – KWD 2.454
1.4 B 1
FY2028 KWD 1.860
KWD 1.568 – KWD 2.379
1.2 B 3
FY2027 KWD 0.833
KWD 0.373 – KWD 1.284
1 B 8

النقاط الرئيسية

Revenue grew 23.34% annually over 5 years — strong growth
Generating 34.52M in free cash flow
Capital efficient — spends only 6.20% of revenue on capex

النمو

Revenue Growth (5Y)
23.34%
Revenue (1Y)26.24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-5.96%
Op. Margin-4.93%

الأمان

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-2.80

التقييم

P/E Ratio
-85.70
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 26.24% Revenue Growth (3Y) 23.15%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 23.34% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 747.14M Net Income (TTM) -44.55M
ROE N/A ROA N/A
Gross Margin 70.57% Operating Margin -4.93%
Net Margin -5.96% Free Cash Flow (TTM) 34.52M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage -2.80 Dividend Yield 0.00%
Valuation
P/E Ratio -85.70 P/B Ratio N/A
P/S Ratio 5.11 PEG Ratio 2.07
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 3.82B Enterprise Value N/A

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 747.14M 591.84M 492.68M 410.92M 322.83M
Net Income -44.55M -113.29M -123.41M -116.16M -101.36M
EPS (Diluted) -1.39 -3.63 -4.04 -3.88 -3.46
Gross Profit 527.25M 407.53M 331.81M 281.63M 213.57M
Operating Income -36.81M -115.51M -125.16M -113.78M -99.94M